| Author (Corporate) | European Commission: DG Communication |
|---|---|
| Series Title | Press Release |
| Series Details | IP/14/229 (10.03.14) |
| Publication Date | 10/03/2014 |
| Content Type | News |
|
On the 10 March 2014, the German biopharmaceutical company CureVac GmbH won the EU's first ever innovation inducement prize. The company received the prize for progress towards a novel technology to bring life-saving vaccines to people across the planet in safe and affordable ways. The European Commission offered the €2 million prize to encourage inventors to overcome one of the biggest barriers to using vaccines in developing countries: the need to keep them stable at any ambient temperature. |
|
| Source Link | Link to Main Source http://europa.eu/rapid/press-release_IP-14-229_en.htm |
| Related Links |
|
| Subject Categories | Culture, Education and Research, Health |
| Countries / Regions | Europe |
